Experienced in Hypercalcemia

Caroline M. Hamm

Windsor, ON, CA 
Experienced in Hypercalcemia
Windsor, ON, CA 
OverviewLocationsClinical Research

Overview

Caroline Hamm practices in Windsor, Canada. Ms. Hamm is rated as an Experienced expert by MediFind in the treatment of Hypercalcemia. Her top areas of expertise are Triple-Negative Breast Cancer, Breast Cancer, Chronic Myelogenous Leukemia (CML), Plasmacytoma, and Splenectomy.

Her clinical research consists of co-authoring 60 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Hypercalcemia.

Gender
Female

Locations

Windsor, ON, Canada
Other Locations
London, ON, Canada
Windsor, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients With High Risk Resected Melanoma
A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients With High Risk Resected Melanoma
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Procedure, Biological
Study Drugs: Ipilimumab, Pembrolizumab, Recombinant Interferon Alfa-2b
Study Phase: Phase 3
A Randomized Phase II, Double Blind Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer Receiving First to Fourth Line Chemotherapy
A Randomized Phase II, Double Blind Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer Receiving First to Fourth Line Chemotherapy
Enrollment Status: Completed
Publish Date: April 14, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Pragmatic Cluster-Randomized Trial of Ambulatory Toxicity Management in Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy for Early Stage Breast Cancer (AToM)
A Pragmatic Cluster-Randomized Trial of Ambulatory Toxicity Management in Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy for Early Stage Breast Cancer (AToM)
Enrollment Status: Completed
Publish Date: September 03, 2020
Intervention Type: Other
Study Phase: Not Applicable
View 2 Less Clinical Trials

60 Total Publications

A Cohort Study Analysing the Impact of the COVID-19 Pandemic on Colorectal Cancer Presentations in a Medium-Large Canadian Community Hospital.
A Cohort Study Analysing the Impact of the COVID-19 Pandemic on Colorectal Cancer Presentations in a Medium-Large Canadian Community Hospital.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: July 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Hamm's expertise for a condition
ConditionClose
      View All 22 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile